AmMax Bio licenses antibody-drug conjugate technology for haematological cancers from Lonza

Endpoints NewsMerck brings Welireg-Keytruda combo to treat kidney cancer

Clinical OMICsFrom Multi-Omics to Digital Twins: A Data-Driven Future for Precision Medicine

Clinical OMICsAge-Related Mutations in Brain Immune Cells Linked to Alzheimer’s Inflammation

Clinical OMICsPaper Mills and the Fight Against Scientific Fraud

Clinical OMICsNanowire Device Captures EVs for Targeted Cancer Liquid Biopsies

CellComplete biosynthesis of the anticancer cephalotaxinone and homoerythratine

Endpoints NewsAmgen and the FDA want two different outcomes for Tavneos. What will patients do?

Endpoints NewsEli Lilly invests in startup Abridge for clinical trial recruitment

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-June 11, 2026

Thermo FisherThermo Fisher Tests SpheriCal Calibration As Potential Edge In Mass Spectrometry - Yahoo Finance

Lonza NewsAmMax Bio licenses antibody-drug conjugate technology for haematological cancers from Lonza - Manufacturing Chemist